Brain computing interface applications find niche in healthcare and patient rehabilitation: New trials could generate further investment as fringe tech makes its way to the mainstream.

The federal gov’t could block the deal (as it’s done for others like it) due to anticompetitive concerns

The US is ready for gamified therapy: Video game-based digital therapeutic pioneer Akili is set to go public later this year. We detail why it won’t be the last of its kind to do so as the number of gamers grows in the US.

A sneak peek into the “healthcare metaverse”: Crozer Health is the first hospital to integrate smart glasses in its first response operations. We detail how the glasses work and how tech like it could be at the helm of the “healthcare metaverse.”

Can AI help put an end to the pandemic? InstaDeep scored $100 million to develop more real-world AI solutions across industries, including pharma. We unpack how the tech could be a key to quickly developing a COVID-19 cure.

Is telehealth’s ROI its post-pandemic saving grace? Cigna-MD Live’s latest study shows how the tech can cut on healthcare costs. We detail what’s behind telehealth’s power to slash costs for both providers and patients.

Candid announced plans to pull out of the direct-to-consumer space, shifting to B2B: The move by the oral care brand illustrates that D2C is not an automatic winner across all categories.

Peloton faces an uphill battle as it struggles with weak demand: New reports paint a picture of a company in crisis, making an acquisition attempt likely.